Literature DB >> 6605971

Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography.

I M Kapetanovic, J D DiGiovanni, J Bartosevich, V Melendez, J Von Bredow, M Heiffer.   

Abstract

An analytical method is described for the quantitation of mefloquine, a new antimalarial agent, in plasma and blood. A structurally similar quinolinemethanol compound, WR 184,806, is used as the internal standard. The method employs a three-step extraction procedure followed by reversed-phase high-performance liquid chromatography, and octanesulfonate is used as an ion-pairing reagent. Detection is achieved at 222 nm. The entire procedure is relatively simple and requires only 1 ml of sample. Good accuracy and precision are obtained over the wide concentration range tested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605971     DOI: 10.1016/s0378-4347(00)84838-0

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.

Authors:  F D Juma; J O Ogeto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

2.  Divided-dose kinetics of mefloquine in man.

Authors:  G Franssen; B Rouveix; J Lebras; J Bauchet; F Verdier; C Michon; F Bricaire
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.

Authors:  J H Rivière; D J Back; A M Breckenridge; R E Howells
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.